|
|

Home > Healthcare > Biotechnology > General Biotech
Parexel International Corporation
 |
| Published Date:
October 2009
Published By:
SGA Lists
Page Count:
5
Order Code:
R406-16685
|
|

| PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of knowledge-based contract research, medical communications and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process.
|
Similar Products
• Algae For Fuel, Algal Oil, Biofuels, Biodiesel, Ethanol And The Future Of Petroleum And Green Energy
Published Nov 2009 by Amadee & Company
• Biotechnology (Pharmaceuticals) Report
Published Nov 2009 by Plimsoll Publishing Ltd.
• Opportunities in Human Embryonic Stem Cell (hESC) Products
Published Nov 2009 by BioInformant Worldwide, L.L.C.
• Global Stem Cell and Advanced Technologies Market
Published Nov 2009 by MarketsandMarkets
• Protein Kinase Therapeutics in Oncology - Where to Commercialize?
Published Oct 2009 by BioSeeker Group AB
• Acorda Therapeutics, Inc. - SWOT Analysis
Published Oct 2009 by Datamonitor
• Future of Green Biotechnology in China
Published Oct 2009 by CCM International Limited
• Scientific Research in Australia - Industry Risk Rating Report
Published Oct 2009 by IBISWorld
• Biotechnology in Australia - Industry Risk Rating Report
Published Oct 2009 by IBISWorld
• Biotechnology in the US - Industry Risk Rating Report
Published Oct 2009 by IBISWorld
|
|
|
|